(62 days)
Not Found
No
The description focuses on the electrical stimulation mechanism and user interface, with no mention of AI/ML capabilities, data analysis for treatment optimization, or adaptive algorithms. The treatments are pre-programmed and selected by the healthcare professional.
Yes
The device description explicitly states, "The BRC 2200 is a non-invasive, therapeutic device."
No
The device description clearly states it is a "non-invasive, therapeutic device that delivers bipolar electrical current" for pain relief, not for diagnosing conditions.
No
The device description explicitly states it is a "non-invasive, therapeutic device that delivers bipolar electrical current" and includes hardware components such as a hand-held device, electrodes, electrode cables, battery, and charger.
Based on the provided information, the BRC 2200 is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for "temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain." This describes a therapeutic device that acts on the body to alleviate pain.
- Device Description: The description details a non-invasive device that delivers electrical current to the body via electrodes applied to the skin. This is consistent with a therapeutic device, not a device used to examine specimens from the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (blood, urine, tissue, etc.) from the human body to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed to perform tests on samples taken from the body. The BRC 2200 delivers treatment to the body.
N/A
Intended Use / Indications for Use
The BRC 2200 is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain.
Product codes
GZJ
Device Description
The BRC 2200 is a non-invasive, therapeutic device that delivers bipolar electrical current. In order to maintain a neutral charge for each cycle, the device delivers a current of one polarity for the first half of the cycle and then the opposite polarity for the second half of the cycle.
The BRC 2200 is a hand-held device with a touch screen designed for ease of the user. The licensed healthcare professional uses a pass code to access screens regarding the treatment options and patient information. The main treatment screen shows the progression of the treatment, date, time, battery level, and gives options to pause the treatment or reduce the power if the patient feels discomfort.
The BRC 2200 contains 24 pre-programmed treatments accessible only to the licensed healthcare professional. Using the designated pass code, the licensed healthcare professional selects the treatment and updates the correct patient information to the device before starting the treatment. Once the treatment has started, the patient will be able to pause the treatment or reduce power if he/she feels mild discomfort.
Components included with the BRC 2200 contain a pair of single-use electrodes, a pair of electrode cables, a battery charger, and an optional USB cable.
The electrodes come in a variety of sizes ranging from extra-small to large and either two inch or three inch widths. The electrodes attach by being circumferentially wrapped around a limb or the trunk of the body and the overlapping ends secured with hook and loop fasteners to maintain circumferential tension during treatment. The electrodes consist of a conductive layer sandwiched between a layer of polyurethane foam and a layer of synthetic neoprene. The foam is in contact with normal, intact skin for up to 3 hours and complies with ISO 10993.
The electrode cables attach to the electrodes via a silver metal hook and loop fastener which then attaches to the BRC 2200 using push-pull connectors. The electrode cables used with the electrodes can be multi-use and are available in 40, 50, and 60 inches in length. These three different sizes in electrode cables allow for differences in the placement of electrodes and the different sizes of patients.
In order to conduct the current through the body, the electrodes require water as the conducting medium. This is achieved by soaking the electrodes in water or normal saline solution and applying to the location in which current flow should be directed.
The BRC 2200 is powered by a Tenergy 3.7V Li-polymer rechargeable battery. The battery is charged by the Tenergy 3.7V Li-ion battery charger model OH-1048A0451500U. The optional USB cable allows the licensed healthcare professional to obtain treatment information and transfer it to a computer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
The BRC 2200 is a prescription device and can be used in a healthcare facility or at home.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-Clinical Testing: Testing of the BRC 2200 includes functional performance testing and electrical safety testing in accordance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-4, and IEC 60601-2-10. Testing of any skin-contacting materials includes biocompatibility testing in accordance with ISO 10993-1, ISO 10993-5, and ISO 10993-10.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).
0
JUL 3 1 2012
510(K) Summary
(Per 21 CFR 807.92)
Applicant
Applicant: Bioelectric Research Corporation 112 N. Curry St. Carson City, NV 89703 Phone: 775-884-1200
Contact: ·
Shepard G. Bentley, RAC President & Principal Consultant Bentley Biomedical Consulting, LLC 28241 Crown Valley Parkway Suite 510(k) Laguna Niguel, CA 92677 Phone: 949-374-9187 Fax: 949-606-8191 sbentley@bentleybiomed.com
Date summary was prepared: July 28, 2012
Predicate Device
The BRC 2200 device is substantially equivalent to the transcutaneous electrical nerve stimulator (TENS) device BodiHealth System (K052836).
Device Description
The BRC 2200 is a non-invasive, therapeutic device that delivers bipolar electrical current. In order to maintain a neutral charge for each cycle, the device delivers a current of one polarity for the first half of the cycle and then the opposite polarity for the second half of the cycle.
The BRC 2200 is a hand-held device with a touch screen designed for ease of the user. The licensed healthcare professional uses a pass code to access screens regarding the treatment options and patient information. The main treatment screen shows the progression of the treatment, date, time, battery level, and gives options to pause the treatment or reduce the power if the patient feels discomfort.
The BRC 2200 contains 24 pre-programmed treatments accessible only to the licensed healthcare professional. Using the designated pass code, the licensed healthcare professional selects the treatment and updates the correct patient information to the
Section 4 - 1
1
K12/578
device before starting the treatment. Once the treatment has started, the patient will be able to pause the treatment or reduce power if he/she feels mild discomfort.
Components included with the BRC 2200 contain a pair of single-use electrodes, a pair of electrode cables, a battery charger, and an optional USB cable.
The electrodes come in a variety of sizes ranging from extra-small to large and either two inch or three inch widths. The electrodes attach by being circumferentially wrapped around a limb or the trunk of the body and the overlapping ends secured with hook and loop fasteners to maintain circumferential tension during treatment. The electrodes consist of a conductive layer sandwiched between a layer of polyurethane foam and a layer of synthetic neoprene. The foam is in contact with normal, intact skin for up to 3 hours and complies with ISO 10993.
The electrode cables attach to the electrodes via a silver metal hook and loop fastener which then attaches to the BRC 2200 using push-pull connectors. The electrode cables used with the electrodes can be multi-use and are available in 40, 50, and 60 inches in length. These three different sizes in electrode cables allow for differences in the placement of electrodes and the different sizes of patients.
In order to conduct the current through the body, the electrodes require water as the conducting medium. This is achieved by soaking the electrodes in water or normal saline solution and applying to the location in which current flow should be directed.
The BRC 2200 is powered by a Tenergy 3.7V Li-polymer rechargeable battery. The battery is charged by the Tenergy 3.7V Li-ion battery charger model OH-1048A0451500U. The optional USB cable allows the licensed healthcare professional to obtain treatment information and transfer it to a computer.
The BRC 2200 is a prescription device and can be used in a healthcare facility or at home.
Indications for Use
The BRC 2200 is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain.
2
Summary of the Technical Characteristics of the BRC2200 as Related to the Predicate Device
| Table 1 | ||
|---|---|---|
| Atom 1 (Model: BRC 2200) | BodiHealth | |
| 510(k) Number | Pending | K052836 |
| Intended Use | The BRC 2200 is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain. | The Bodihealth System is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain. |
| Power Source | Tenergy Li-ion battery 3.7V - 3Ah | Sealed lead acid rechargeable battery 6V - 4Ah |
| - Method of Line Current Isolation | N/A | N/A |
| - Patient Leakage Current | N/A | N/A |
| - Normal Condition (μΑ) | N/A | N/A |
| - Single Fault Condition (μA) | N/A | N/A |
| Average DC current through electrodes when device is on but no pulses are being applied (µΑ) | 0.002 μΑ | 0.002 μΑ |
| Number of Output Modes | 24 | 26 |
| Number of Output Channels | 1 | 1 |
| Regulated Current or Regulated Voltage? | Regulated current | Regulated current |
| Software/Firmware/Microprocessor Control? | Yes | Yes |
| Automatic Overload Trip? | Yes | Yes |
| Automatic No-Load Trip? | No | No |
| Automatic Shut Off? | Yes | No |
| Indicator Display: On/Off Status? | Yes | Yes |
| Indicator Display: Low Battery? | Yes | Yes |
| Indicator Display: Voltage/Current Level? | Yes | No |
| Indicator Display: Open Circuit? | Yes | Yes |
| Timer Range (minutes) | 92-161 minutes | User-controlled with |
| 23 minute cycles. | ||
| Compliance with Voluntary | ||
| Standards? | No | No |
| Compliance with 21 CFR 898? | Yes | Yes |
| Weight (lbs., oz.) | 10.5 oz. | 7 lbs., 3 oz. |
| Dimensions (in.) [W x H x D] | 5.9 in. x 3.75 in. x 1.5 in. | 9 in. x 4.5 in. x 11 in. |
| Housing Materials and Construction | Injection-molded plastic | |
| case | Injection-molded | |
| plastic case | ||
| Mode or Program Name | Treatment G, H, or I, | |
| Cycle 3 | Treatment C | |
| Waveform (e.g., pulsed monophasic, | ||
| biphasic) | Biphasic | Biphasic |
| Shape (e.g., rectangular, spike, | ||
| rectified sinusoidal) | Rectangular | Rectangular |
| Maximum Output Voltage (volts) | ||
| (+/- 5%) | 1.5V@500 Ω | |
| 6V@2 kΩ | ||
| 30V@10kΩ | 1.5V@500 Ω | |
| 6V@2 KΩ | ||
| 25V@10kΩ | ||
| Maximum Output Current (specify | ||
| units) (+/- 5%) | 3mA@500 Ω | |
| 3mA@2 kΩ | ||
| 3mA@10kΩ | 3mA@500 Ω | |
| 3mA@2 kΩ | ||
| 2.5mA@ 10 kΩ | ||
| Duration of primary (depolarizing) | ||
| phase (µsec) | N/A | N/A |
| Pulse duration (usec) | 100 ms | 128 ms |
| Frequency (Hz) [or Rate pps] | 10 Hz | 7.8 Hz |
| Net Charge (microcoulombs (µC) per | ||
| pulse) (If zero, state method of | ||
| achieving zero net charge) | 0 µC @500Ω | |
| Symmetrical waveform | 0 µC @500Ω | |
| Symmetrical waveform | ||
| Maximum Phase Charge (μC) | 3 µC @500Ω | 4.3 µC @500Ω |
| Maximum Current Density (mA/cm2, | ||
| r.m.s.) | 0.0205 mA/cm²@500Ω | |
| (3mA/146.577 cm²) | 0.0089 | |
| mA/ cm²@500Ω | ||
| (3mA/338.7 cm²) | ||
| Maximum Average Current (average | ||
| absolute value) mA | 3mA@500Ω | 3mA@500Ω |
| Maximum Average Power Density | ||
| (W/cm²) (using smallest electrode | ||
| conductive surface area) | 30.7μW/ cm² @500Ω | |
| (0.0045/146.577) | 13.297μW/ cm² | |
| @500Ω | ||
| (0.0045/338.7) | ||
| ON Time (seconds) | 9660 seconds | |
| (maximum treatment | ||
| time) | User-controlled | |
| Additional Features (specify, if | ||
| applicable) | Data-logging |
3
:
.
·
4
Non-Clinical Testing
Testing of the BRC 2200 includes functional performance testing and electrical safety testing in accordance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-4, and IEC 60601-2-10. Testing of any skin-contacting materials includes biocompatibility testing in accordance with ISO 10993-1, ISO 10993-5, and ISO 10993-10.
Conclusions
In comparison to the BodiHealth System, the BRC 2200 is substantially equivalent and has similar technical, functional, and performance characteristics. The BRC 2200 is designed to comply with the generally accepted performance specifications for TENS devices. The BRC 2200 performs as intended and does not raise any new safety or efficacy issues.
5
Image /page/5/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, enclosed within a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle.
· Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JUL 3 1 2012
Bioelectric Research Corporation c/o Ms. Paula Wilkerson Sr. Staff Engineer, Sr. Reviewer, Program Manager Intertek Testing Services 2307 E. Aurora Rd. Unit B7 Twinsburg, OH 44087
Re: K121578
Trade/Device Name: Atom 1, Model BRC 2200 Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Code: GZJ Dated: July 13, 2012 Received: July 16, 2012
Dear Ms. Wilkerson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
6
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
n
Sincerely yours,
Kesia Alexander
Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number (if known): K12/ 578
Device Name: Atom 1
Model: BRC 2200
Indications for Use:
The BRC 2200 is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post-surgical and post-traumatic pain.
AND/OR Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use _ (Part 21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ONTO ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
CLLCY
(Division Sign-Off)
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number 15121578